Switching Lamivudine with Adefovir Dipivoxil Combination Therapy to Entecavir Monotherapy Provides Better Viral Suppression and Kidney Safety

Introduction: Most chronic hepatitis B (CHB) patients in China are primitively treated with a combination of lamivudine (LAM) and adefovir dipivoxil (ADV). Although antiviral resistance can be avoided with this combination therapy, using it can have harmful side effects related to ADV, specifically...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int J Med Sci
Main Authors: Lian, Jiang-Shan, Zhang, Xiao-Lin, Lu, Ying-Feng, Chen, Jian-Yang, Zhang, Yi-Min, Jia, Hong-Yu, Zhang, Zhe, Yang, Yi-Da
Format: Artigo
Sprog:Inglês
Udgivet: Ivyspring International Publisher 2019
Fag:
Research Paper
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6332476/
https://ncbi.nlm.nih.gov/pubmed/30662324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.28700
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker